Glycan profiling of multiple sclerosis oligoclonal bands with MALDI-TOF

Area of Science:

• Neuroimmunology
• Glycomics
• Biomarker Discovery

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease impacting the central nervous system.
• The immune system mistakenly attacks the myelin sheath, causing neurological dysfunction.
• Oligoclonal bands (OCBs) in cerebrospinal fluid (CSF) are key diagnostic markers for MS.

Purpose of the Study:

• To investigate IgG glycosylation patterns in patients with suspected MS.
• To compare IgG glycan profiles across different OCB types.
• To explore the potential of IgG glycans as diagnostic biomarkers for MS.

Main Methods:

• Serum samples from patients suspected of having MS were analyzed.
• Glycan analysis was performed using MALDI-TOF mass spectrometry.
• IgG glycosylation patterns were compared between different OCB status groups.

Main Results:

• Distinct alterations in IgG glycosylation profiles were observed in MS patients.
• Specific glycan changes correlated with different OCB types.
• These findings suggest IgG glycans are sensitive to MS-related immune dysregulation.

Conclusions:

• Altered IgG glycans represent potential novel biomarkers for MS diagnosis.
• Glycomic analysis provides insights into MS pathogenesis.
• This research supports the development of advanced diagnostic tools for MS.